CELU
Price
$1.34
Change
+$0.03 (+2.29%)
Updated
Mar 11 closing price
Capitalization
31.31M
NVCT
Price
$7.33
Change
-$0.29 (-3.81%)
Updated
Mar 11 closing price
Capitalization
171.46M
62 days until earnings call
Ad is loading...

CELU vs NVCT

Header iconCELU vs NVCT Comparison
Open Charts CELU vs NVCTBanner chart's image
Celularity
Price$1.34
Change+$0.03 (+2.29%)
Volume$59.11K
Capitalization31.31M
Nuvectis Pharma
Price$7.33
Change-$0.29 (-3.81%)
Volume$86.63K
Capitalization171.46M
CELU vs NVCT Comparison Chart
Loading...
CELU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CELU vs. NVCT commentary
Mar 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CELU is a Hold and NVCT is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 12, 2025
Stock price -- (CELU: $1.32 vs. NVCT: $7.33)
Brand notoriety: CELU and NVCT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CELU: 31% vs. NVCT: 79%
Market capitalization -- CELU: $31.31M vs. NVCT: $171.46M
CELU [@Biotechnology] is valued at $31.31M. NVCT’s [@Biotechnology] market capitalization is $171.46M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.07B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CELU’s FA Score shows that 0 FA rating(s) are green whileNVCT’s FA Score has 0 green FA rating(s).

  • CELU’s FA Score: 0 green, 5 red.
  • NVCT’s FA Score: 0 green, 5 red.
According to our system of comparison, both CELU and NVCT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CELU’s TA Score shows that 5 TA indicator(s) are bullish while NVCT’s TA Score has 5 bullish TA indicator(s).

  • CELU’s TA Score: 5 bullish, 4 bearish.
  • NVCT’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both CELU and NVCT are a good buy in the short-term.

Price Growth

CELU (@Biotechnology) experienced а +21.76% price change this week, while NVCT (@Biotechnology) price change was +15.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.43%. For the same industry, the average monthly price growth was -8.50%, and the average quarterly price growth was -7.70%.

Reported Earning Dates

CELU is expected to report earnings on May 14, 2024.

NVCT is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+0.43% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NVCT($171M) has a higher market cap than CELU($31.3M). NVCT YTD gains are higher at: 35.490 vs. CELU (-36.779). NVCT has higher annual earnings (EBITDA): -20.26M vs. CELU (-21.59M). NVCT has more cash in the bank: 17.2M vs. CELU (133K). CELU has higher revenues than NVCT: CELU (48.2M) vs NVCT (0).
CELUNVCTCELU / NVCT
Capitalization31.3M171M18%
EBITDA-21.59M-20.26M107%
Gain YTD-36.77935.490-104%
P/E RatioN/AN/A-
Revenue48.2M0-
Total Cash133K17.2M1%
Total Debt69.1MN/A-
TECHNICAL ANALYSIS
Technical Analysis
CELUNVCT
RSI
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
70%
Bullish Trend 1 day ago
88%
MACD
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
66%
Bullish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 3 days ago
88%
Declines
ODDS (%)
Bearish Trend 6 days ago
79%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
79%
Bullish Trend 1 day ago
72%
View a ticker or compare two or three
Ad is loading...
CELU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LQDA13.890.06
+0.43%
Liquidia Corp
ESGR331.700.10
+0.03%
Enstar Group Limited
AME178.86-0.51
-0.28%
Ametek
TCBX31.86-0.37
-1.15%
Third Coast Bancshares
MRM0.64-0.01
-1.95%
MEDIROM Healthcare Technologies

CELU and

Correlation & Price change

A.I.dvisor tells us that CELU and NVCT have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CELU and NVCT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CELU
1D Price
Change %
CELU100%
+0.38%
NVCT - CELU
28%
Poorly correlated
-3.81%
CYBN - CELU
28%
Poorly correlated
-2.46%
FATE - CELU
27%
Poorly correlated
+3.57%
PRAX - CELU
27%
Poorly correlated
+3.84%
MRKR - CELU
27%
Poorly correlated
-5.23%
More